Home/Filings/4/0001562180-16-003199
4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001562180-16-003199

CIK 0000835887operating

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 2:57 PM ET

Size

5.3 KB

Accession

0001562180-16-003199

Insider Transaction Report

Form 4
Period: 2016-10-03
Tenbarge Bryce
Vice President, Commercial
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2016-10-03+75,00075,000 total
    Exercise: $6.77Exp: 2026-10-03Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]5yr 20% On Vest beginning on 01-SEP-2016

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000835887

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 2:57 PM ET
Size
5.3 KB